Literature DB >> 33589630

"Hot cross bun" is a potential imaging marker for the severity of cerebellar ataxia in MSA-C.

Shuzhen Zhu1,2, Bin Deng2, Zifeng Huang2, Zihan Chang2, Hualin Li2, Hui Liu2, Yanjun Huang2, Ying Pan3, Yanping Wang3, Yin-Xia Chao4, Ling-Ling Chan4, Yih-Ru Wu5, Eng-King Tan6, Qing Wang7,8.   

Abstract

To evaluate the correlation between "hot cross bun" sign (HCBs) and disease severity in multiple system atrophy (MSA). We recruited patients with probable and possible MSA with parkinsonism (MSA-P) or the cerebellar ataxia (MSA-C) subtypes. Clinical and imaging characteristics were collected and comparison was performed between MSA-C and MSA-P cases. Spearman test was used to evaluate the correlation between HCBs and other variables. Curve estimate and general linear regression was performed to evaluate the relationship between HCBs and the Scale for Assessment and Rating of Ataxia (SARA). Unified Multiple System Atrophy Rating Scale (UMSARS) IV was used to assess the severity of disease. Multinomial ordered logistic regression was used to confirm the increased likelihood of disability for the disease. Eighty-one MSA with HCBs comprising of 50 MSA-C and 31 MSA-P were recruited. We demonstrated that the severity of HCBs showed a positive linear correlation with SARA scores in MSA-C. Multinomial ordered logistic regression test revealed that the increase in the HCBs grade may be associated with an increased likelihood of disability for the disease severity in MSA, especially in those with cerebellar ataxia subtype. We demonstrated that HCBs is a potential imaging marker for the severity of cerebellar ataxia. The increase in the HCBs grade may be associated with an increased likelihood of disability in MSA-C, but not MSA-P cases, suggesting that it may be a useful imaging indicator for disease progression in Chinese patients with MSA-C.

Entities:  

Year:  2021        PMID: 33589630     DOI: 10.1038/s41531-021-00159-w

Source DB:  PubMed          Journal:  NPJ Parkinsons Dis        ISSN: 2373-8057


  7 in total

1.  Radiological hints for differentiation of cerebellar multiple system atrophy from spinocerebellar ataxia.

Authors:  Jiing-Feng Lirng; Bing-Wen Soong; Hung-Chieh Chen; Li-Hua Lee
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

2.  Integrative Analysis of lncRNA and mRNA and Profiles in Postoperative Delirium Patients.

Authors:  Yuxiang Song; Xiaoyan Wang; Aisheng Hou; Hao Li; Jingsheng Lou; Yanhong Liu; Jiangbei Cao; Weidong Mi
Journal:  Front Aging Neurosci       Date:  2021-05-19       Impact factor: 5.750

3.  Retinal Nerve Fiber Layer Thickness and Associations With Cognitive Impairment in Parkinson's Disease.

Authors:  Zihan Chang; Fen Xie; Hualing Li; Feilan Yuan; Lina Zeng; Lin Shi; Shuzhen Zhu; Xiaohe Lu; Xiaobo Wei; Qing Wang
Journal:  Front Aging Neurosci       Date:  2022-02-10       Impact factor: 5.750

4.  Erythrocytes Are an Independent Protective Factor for Vascular Cognitive Impairment in Patients With Severe White Matter Hyperintensities.

Authors:  Xi Tao; Hang Zhou; Danheng Mo; Wenjie Zhang; Zihan Chang; Yiheng Zeng; Yuqi Luo; Siyuan Wu; Wenjing Tang; Chen Yang; Qing Wang
Journal:  Front Aging Neurosci       Date:  2022-02-18       Impact factor: 5.750

5.  Profiling of Differentially Expressed MicroRNAs in Saliva of Parkinson's Disease Patients.

Authors:  Yanyan Jiang; Jing Chen; Yunchuang Sun; Fan Li; Luhua Wei; Wei Sun; Jianwen Deng; Yun Yuan; Zhaoxia Wang
Journal:  Front Neurol       Date:  2021-11-26       Impact factor: 4.003

6.  Efficacy of repetitive transcranial magnetic stimulation in Parkinson's disease: A systematic review and meta-analysis of randomised controlled trials.

Authors:  Wenjie Zhang; Bin Deng; Fen Xie; Hang Zhou; Ji-Feng Guo; Hong Jiang; Amy Sim; Beisha Tang; Qing Wang
Journal:  EClinicalMedicine       Date:  2022-07-29

Review 7.  The influence of white matter hyperintensity on cognitive impairment in Parkinson's disease.

Authors:  Hailing Liu; Bin Deng; Fen Xie; Xiaohua Yang; Zhenchao Xie; Yonghua Chen; Zhi Yang; Xiyan Huang; Shuzhen Zhu; Qing Wang
Journal:  Ann Clin Transl Neurol       Date:  2021-07-26       Impact factor: 4.511

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.